The Food and Drug Administration today authorized both Pfizer and Moderna to give a second booster dose of their COVID-19 vaccines to individuals 50 years of age and older and to those who are immunocompromised.
The additional shot follows completion of a three-dose primary vaccination series at least four months after the first booster.
